Award
Delivery Order #SPE2DR26F9TT3
Delivery Order to AmerisourceBergen for Erlotinib Tablets
Buyer
Defense Logistics Agency
Award Amount
$3,785.11
Ceiling
$3,785.11
Awarded
March 03, 2026
Period of Performance
Mar 03, 2026 – Mar 04, 2026
Identifier
SPE2DR26F9TT3
NAICS
424210
This award is a delivery order contract awarded to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, under a significant long-term indefinite delivery vehicle contract. The order procures Erlotinib HCL 150 MG tablets, a critical pharmaceutical product used in cancer treatment, ensuring timely access to essential medication. The contract's scope encompasses the provision and delivery of this specific pharmaceutical product to the designated location in Conshohocken, PA, within a short performance window. This allocation is part of the broader AmerisourceBergen contract supporting efficient medication supply chains for healthcare agencies. The delivery order was competitively executed within the framework of the existing indefinite delivery contract, demonstrating the agency's commitment to maintaining reliable pharmaceutical supplies. The transaction reflects ongoing healthcare support efforts planned for near-term fulfillment.
Description
4571009073!ERLOTINIB HCL 150 MG TABLET 30S